Suppr超能文献

二苯乙烯类化合物:从民间传说到药物创新的历程。

Stilbenes: a journey from folklore to pharmaceutical innovation.

机构信息

University Institute of Biotechnology, Chandigarh University, Mohali, 140413, Punjab, India.

Department of Plant Sciences, University of Idaho Moscow, Idaho, ID, 83844, USA.

出版信息

Arch Microbiol. 2024 Apr 22;206(5):229. doi: 10.1007/s00203-024-03939-z.

Abstract

In modern times, medicine is predominantly based on evidence-based practices, whereas in ancient times, indigenous people relied on plant-based medicines with factual evidence documented in ancient books or folklore that demonstrated their effectiveness against specific infections. Plants and microbes account for 70% of drugs approved by the USFDA (U.S. Food and Drug Administration). Stilbenes, polyphenolic compounds synthesized by plants under stress conditions, have garnered significant attention for their therapeutic potential, bridging ancient wisdom with modern healthcare. Resveratrol, the most studied stilbene, initially discovered in grapes, red wine, peanuts, and blueberries, exhibits diverse pharmacological properties, including cardiovascular protection, antioxidant effects, anticancer activity, and neuroprotection. Traditional remedies, documented in ancient texts like the Ayurvedic Charak Samhita, foreshadowed the medicinal properties of stilbenes long before their modern scientific validation. Today, stilbenes are integral to the booming wellness and health supplement market, with resveratrol alone projected to reach a market value of 90 million US$ by 2025. However, challenges in stilbene production persist due to limited natural sources and costly extraction methods. Bioprospecting efforts reveal promising candidates for stilbene production, particularly endophytic fungi, which demonstrate high-yield capabilities and genetic modifiability. However, the identification of optimal strains and fermentation processes remains a critical consideration. The current review emphasizes the knowledge of the medicinal properties of Stilbenes (i.e., cardiovascular, antioxidant, anticancer, anti-inflammatory, etc.) isolated from plant and microbial sources, while also discussing strategies for their commercial production and future research directions. This also includes examples of novel stilbenes compounds reported from plant and endophytic fungi.

摘要

在现代,医学主要基于循证实践,而在古代,土著居民依赖基于植物的药物,这些药物在古代书籍或民间传说中有事实证据证明其对特定感染的有效性。植物和微生物占美国食品和药物管理局 (USFDA) 批准药物的 70%。植物在应激条件下合成的多酚类化合物——芪类,因其治疗潜力而备受关注,将古代智慧与现代医疗保健联系起来。白藜芦醇是研究最多的芪类,最初在葡萄、红酒、花生和蓝莓中发现,具有多种药理特性,包括心血管保护、抗氧化作用、抗癌活性和神经保护作用。传统疗法,如阿育吠陀 Charak Samhita 等古代文献中记载,早在其现代科学验证之前,就预示了芪类的药用特性。如今,芪类是蓬勃发展的健康和保健品市场的重要组成部分,仅白藜芦醇预计到 2025 年市场价值将达到 9000 万美元。然而,由于天然资源有限和昂贵的提取方法,芪类的生产仍面临挑战。生物勘探工作揭示了具有生产芪类潜力的有前途的候选者,特别是内生真菌,它们具有高产能力和遗传可修饰性。然而,最佳菌株和发酵工艺的确定仍然是一个关键考虑因素。本综述强调了从植物和微生物来源分离的芪类(即心血管、抗氧化、抗癌、抗炎等)的药用特性的知识,同时还讨论了其商业生产的策略和未来的研究方向。这还包括从植物和内生真菌中报道的新型芪类化合物的例子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验